414 Leveraging modular TriKE-PACC molecules capable of dual-antigen targeting to enhance NK-cell immunotherapy in AML.
Objectives/Goals: Acute myeloid leukemia (AML) is an aggressive blood cancer that hides from the immune system, which led to ~140,000 deaths worldwide in 2024. AML often recurs or resists therapy; therefore, our goal is to develop and test TriKE-PACCs, which combine dual tumor antigen targeting with...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cambridge University Press
2026-04-01
|
| Serier: | Journal of Clinical and Translational Science |
| Online adgang: | https://www.cambridge.org/core/product/identifier/S2059866126105664/type/journal_article |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|